Tinzaparin

Revision as of 19:22, 29 May 2009 by Brian Blank (talk | contribs)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Tinzaparin
Clinical data
ATC code
Identifiers
CAS Number
E number{{#property:P628}}
ECHA InfoCard{{#property:P2566}}Lua error in Module:EditAtWikidata at line 36: attempt to index field 'wikibase' (a nil value).

WikiDoc Resources for Tinzaparin

Articles

Most recent articles on Tinzaparin

Most cited articles on Tinzaparin

Review articles on Tinzaparin

Articles on Tinzaparin in N Eng J Med, Lancet, BMJ

Media

Powerpoint slides on Tinzaparin

Images of Tinzaparin

Photos of Tinzaparin

Podcasts & MP3s on Tinzaparin

Videos on Tinzaparin

Evidence Based Medicine

Cochrane Collaboration on Tinzaparin

Bandolier on Tinzaparin

TRIP on Tinzaparin

Clinical Trials

Ongoing Trials on Tinzaparin at Clinical Trials.gov

Trial results on Tinzaparin

Clinical Trials on Tinzaparin at Google

Guidelines / Policies / Govt

US National Guidelines Clearinghouse on Tinzaparin

NICE Guidance on Tinzaparin

NHS PRODIGY Guidance

FDA on Tinzaparin

CDC on Tinzaparin

Books

Books on Tinzaparin

News

Tinzaparin in the news

Be alerted to news on Tinzaparin

News trends on Tinzaparin

Commentary

Blogs on Tinzaparin

Definitions

Definitions of Tinzaparin

Patient Resources / Community

Patient resources on Tinzaparin

Discussion groups on Tinzaparin

Patient Handouts on Tinzaparin

Directions to Hospitals Treating Tinzaparin

Risk calculators and risk factors for Tinzaparin

Healthcare Provider Resources

Symptoms of Tinzaparin

Causes & Risk Factors for Tinzaparin

Diagnostic studies for Tinzaparin

Treatment of Tinzaparin

Continuing Medical Education (CME)

CME Programs on Tinzaparin

International

Tinzaparin en Espanol

Tinzaparin en Francais

Business

Tinzaparin in the Marketplace

Patents on Tinzaparin

Experimental / Informatics

List of terms related to Tinzaparin

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Please Join in Editing This Page and Apply to be an Editor-In-Chief for this topic: There can be one or more than one Editor-In-Chief. You may also apply to be an Associate Editor-In-Chief of one of the subtopics below. Please mail us [2] to indicate your interest in serving either as an Editor-In-Chief of the entire topic or as an Associate Editor-In-Chief for a subtopic. Please be sure to attach your CV and or biographical sketch.

Overview

Tinzaparin is an antithrombotic in the heparin group.

External links

  • tinzaparin at the US National Library of Medicine Medical Subject Headings (MeSH)
  • http://uuhsc.utah.edu/pharmacy/bulletins/tinzaparin.html
  • Sprigg N, Gray LJ, Bath PM; et al. (2007). "Early recovery and functional outcome are related with causal stroke subtype: data from the tinzaparin in acute ischemic stroke trial". Journal of stroke and cerebrovascular diseases : the official journal of National Stroke Association. 16 (4): 180–4. doi:10.1016/j.jstrokecerebrovasdis.2007.02.003. PMID 17689415.

Template:WikiDoc Sources